OSE Pharma SA (OSE) — Capital Reinvestment Ratio
Latest as of June 2024:
0.00x
OSE Pharma SA (OSE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (€66.63 Million) in capital expenditures (€18.00K). See OSE free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
€66.63 Million
EUR
Capital Expenditures
€18.00K
EUR
Data as of
Jun 2024
Most recent filing
OSE Pharma SA Capital Reinvestment Ratio (2016–2024)
This chart tracks OSE Pharma SA's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for OSE Pharma SA (2016–2024)
Year-by-year Capital Reinvestment Ratio for OSE Pharma SA from 2016 to 2024. For live market cap and broader valuation context, see OSE company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | €48.44 Million | €77.00K | ▼ -95.8% |
| 2019 | 0.04x | €8.97 Million | €336.00K | ▼ -93.2% |
| 2018 | 0.55x | €1.08 Million | €593.00K | ▲ +1155.4% |
| 2016 | 0.04x | €684.00K | €30.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow